← Back to Briefing

CVS to pay $36.5M to resolve Medicaid insulin overbilling allegations

CVS to pay $36.5M to resolve Medicaid insulin overbilling allegations

According to the attorney general, CVS knowingly dispensed more insulin than patients needed between 2010 and 2020 while reporting that prescriptions were correct.

Story image
Continue reading

This preview is provided by The Woodlands News. Full article available at .